Garth Lees-Rolfe - Chief Financial Officer at Inhibikase Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
IKT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Garth Lees-Rolfe since 12/23/2023

Holdings reported by Garth Lees-Rolfe for Inhibikase Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 90K Apr 1, 2024 Direct Common Stock

Transactions reported by Garth Lees-Rolfe for Inhibikase Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.